Abstract:Cutaneous melanoma (CM) is the most serious form of skin cancer. DNA repair has been implicated in the etiology of CM in patients of xeroderma pigmentosum (XP), an autosomal recessive genetic disorder of DNA repair. We have reported that reduced cellular DNA repair capacity (DRC, as assessed by an in vitro lymphocyte-based assay) for removing UV-induced DNA damage is an independent risk factor for sporadic CM and may contribute to susceptibility to sunlight-induced CM in the general population. Recently, we completed a genome-wide association study (GWAS) of melanoma and we also have data on DRC phenotype measured as luciferase activity in the in vitro host-cell reactivation assay using study subjects' lymphocytes for 1042 CM patients. The life-style questionnaire data are also available for these patients included in the GWAS. This is a unique study population and opportunity for us to identify genetic predictors of DRC in CM patients using a genome-wide approach. We found that the DRC varies 6 folds among 1042 CM patients and that the history of sunburn modified the DRC levels. However, we did not find the significant difference within categories of other demographic, exposure and clinical factors including age, sex, smoking and drinking status, the presence of moles and dysplastic nevi, family history of any cancer in first-degree relatives, eye color, hair color, skin color, freckling in the sun as a child, tanning ability, tumor stage, thickness, clark level, ulceration and anatomic site. We applied a generalized linear model with SNPs as predictors and DRC (a continuous variable) as the outcome. The covariates of age, sex, DRC assay-related variables were adjusted in the model. Several suggestive loci contributing to the DRC phenotype have been identified at the significance level of 10−5, including rs1799787 (intron) and rs1799793 (codon 312) in ERCC2/XPD in all CM patients, and rs12342322 near RASEF in 931 CM patients with stage I – IV. The results indicate that DRC phenotype is genetically determined by the genes involved in the nucleotide excision repair pathway and that newly identified SNPs may help understand the underlying mechanism in DRC's role in CM initiation and progression [This work was supported by National Institute of Health grants R01CA100264 (Q. Wei), P50CA093459 (E. Grimm), and P30 CA016672 (The University of Texas M. D. Anderson Cancer Center)]. Citation Format: Li-E Wang, Hongliang Liu, Jeffrey E. Gershenwald, Victor G. Prieto, Elizabeth A. Grimm, Jeffery E. Lee, Christopher I. Amos, Qingyi Wei. Genetic predictors of DNA repair capacity in melanoma patients: A genome-wide approach. [abstract]. In: Proceedings of the AACR Special Conference on Post-GWAS Horizons in Molecular Epidemiology: Digging Deeper into the Environment; 2012 Nov 11-14; Hollywood, FL. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2012;21(11 Suppl):Abstract nr 66.

Family Risk Discussions after Feedback on Genetic Risk of Melanoma.

Interpretation of Melanoma Risk Feedback in First-Degree Relatives of Melanoma Patients.

Patterns and Sources of Information about Family Melanoma Risk among Melanoma Survivors.

Communication about melanoma and risk reduction after melanoma diagnosis

Comprehension of Skin Cancer Genetic Risk Feedback in Primary Care Patients.

Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk

Effects of web-based intervention on risk reduction behaviors in melanoma survivors

Evaluating an approach for communicating integrated risk scores for melanoma

Psychosocial and Cultural Determinants of Interest and Uptake of Skin Cancer Genetic Testing in Diverse Primary Care.

Changes in Skin Cancer-Related Behaviors, Distress, and Beliefs in Response to Receipt of Low- to Moderate-Penetrance Genetic Test Results for Skin Cancer Risk

Genetic testing for familial melanoma

Pediatric Melanoma in Melanoma-Prone Families.

Interaction of Molecular Alterations with Immune Response in Melanoma

Genome-wide Association Meta-Analyses Combining Multiple Risk Phenotypes Provide Insights into the Genetic Architecture of Cutaneous Melanoma Susceptibility

Interest and Uptake of MC1R Testing for Melanoma Risk in a Diverse Primary Care Population A Randomized Clinical Trial

Effects of Health Literacy Skills, Educational Attainment, and Level of Melanoma Risk on Responses to Personalized Genomic Testing.

Risks of Melanoma and Other Cancers in Melanoma-Prone Families over 4 Decades

Integrated Analysis of Coexpression and Exome Sequencing to Prioritize Susceptibility Genes for Familial Cutaneous Melanoma.

Exploring the role of cancer fatalism and engagement with skin cancer genetic information in diverse primary care patients

Abstract 66: Genetic predictors of DNA repair capacity in melanoma patients: A genome-wide approach.

The Impact of Longitudinal Surveillance on Tumor Thickness for Melanoma-Prone Families with and without Pathogenic Germline Variants of <i>CDKN2A</i> and <i>CDK4</i>